Welcome to our dedicated page for Knowles SEC filings (Ticker: KN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Knowles Corporation (NYSE: KN) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Knowles is a manufacturer of specialty electronic components, including high-performance capacitors, RF and RF/Microwave filters, advanced medtech microphones, balanced armature speakers, miniaturization products, and High-Q ceramic core inductors, serving MedTech, Defense, Industrial, and Electrification / Energy markets.
Through this page, users can review core filings such as annual and quarterly reports, which describe results from continuing operations, segment performance for areas like Precision Devices and MedTech & Specialty Audio, and details on items including restructuring charges, impairment charges, stock-based compensation, and cash provided by operating activities. Current reports on Form 8-K, such as those filed on dates when Knowles announces quarterly results, are also available and typically include the related earnings press release and presentation slides.
Stock Titan enhances these filings with AI-powered summaries that are designed to highlight key points from lengthy documents. For example, AI-generated overviews can help surface major trends in revenues from continuing operations, non-GAAP metrics, and commentary on order activity and backlog that management discusses in connection with its results.
In addition, this page can be used to follow Knowles’ use of non-GAAP financial measures, as the company regularly reconciles GAAP and non-GAAP figures in its earnings materials. Real-time updates from EDGAR, combined with AI explanations, allow users to quickly identify new filings, understand their main themes, and locate information relevant to KN stock, such as earnings releases furnished on Form 8-K.
Knowles Corporation (KN)11/21/2025, the executive sold a total of 30,000 shares of Knowles common stock in three separate open-market transactions. The reported weighted average sale prices were $20.90, $20.80, and $21.50 per share.
The filing notes that for the two weighted-average prices, the shares were sold in multiple trades within price ranges of $20.67–$21.055 and $20.75–$20.89, and detailed breakdowns are available upon request. After these sales, the executive directly holds 217,299 shares of Knowles common stock.
A holder of KN common stock filed a Form 144 notice to sell up to 30,000 shares through Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an stated aggregate market value of $631,941.00. The filing notes that 85,151,884 shares of the same class of common stock are outstanding, giving a sense of the sale’s relative size. The approximate sale date disclosed is 11/21/2025. The shares to be sold were acquired from the issuer through a mix of exercised shares, restricted stock, and performance shares granted between 2021 and 2024.
Ariel Investments, LLC filed Amendment No. 4 to Schedule 13G reporting beneficial ownership in Knowles Corp (KN). Ariel reports 4,108,160 shares beneficially owned, representing 4.8% of the common stock, as of the event date 09/30/2025.
The firm has sole voting power over 3,752,222 shares and sole dispositive power over 4,108,160 shares, with no shared voting or dispositive power. Ariel states the holdings were acquired and are held in the ordinary course of business and not to change or influence control. Ariel’s adviser clients have the right to receive dividends or sale proceeds; none hold more than 5%.
Knowles (KN) President & CEO and Director Jeffrey Niew reported option exercises and open-market sales. He exercised non-qualified stock options at $16.07 for 98,252 shares on 10/31/2025 and 38,404 shares on 11/03/2025, then sold the same amounts at weighted average prices of $23.7148 and $23.5498, respectively. Following these transactions, he directly owned 939,370 shares.
The option entries list grant terms with a date exercisable of 02/19/2020 and an expiration date of 02/19/2026. The footnotes state the sales were executed in multiple trades within price ranges of $23.70–$23.81 and $23.40–$23.68, with full trade details available upon request.
Franklin Mutual Advisers, LLC filed a Schedule 13G disclosing a passive beneficial ownership in Knowles Corporation (KN). The firm reported 4,557,663 shares of Knowles common stock, representing 5.3% of the class as of 09/30/2025.
Franklin Mutual Advisers reported sole voting power over 4,300,173 shares and sole dispositive power over 4,557,663 shares, with no shared voting or dispositive power. The filing states the securities are held in the ordinary course and not to change or influence control. The position is held on behalf of the firm’s investment management clients, who have rights to dividends and sale proceeds.
Knowles (KN) filed a Form 144 notice for a proposed sale of 38,404 shares of common stock, with an aggregate market value of $904,402.68. The shares were acquired via a stock option exercise on the same date listed for sale and paid in cash. The filing lists Morgan Stanley Smith Barney LLC as broker and identifies the NYSE as the exchange, with an approximate sale date of 11/03/2025. As context, 85,151,884 shares were outstanding. The notice also reports a recent sale by the same individual of 98,252 shares on 10/31/2025 for $2,330,026.53 in gross proceeds.
Knowles (KN) had a Form 144 notice filed for a proposed sale of up to 98,252 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, reflecting an approximate aggregate market value of $2,330,026.53. The filer lists an approximate sale date of October 31, 2025.
The shares were acquired on October 31, 2025 via a stock option exercise from the issuer, paid in cash. The filing also lists 85,151,884 shares outstanding. Form 144 is a notice of intent to sell restricted or control securities under Rule 144; any actual sales would follow the rule’s conditions.
Knowles Corporation (KN) reported stronger quarterly results. For the three months ended September 30, 2025, revenue was $152.9 million, up from $142.5 million, driven by higher demand in Precision Devices and steady MedTech & Specialty Audio activity. Operating earnings rose to $25.8 million from $18.7 million as gross profit improved to $69.9 million.
Earnings from continuing operations were $18.0 million, or $0.21 per diluted share, versus $0.10 a year ago, helped by lower interest expense. Discontinued operations related to the 2024 sale of Consumer MEMS Microphones contributed a $0.6 million loss. Year to date, revenue reached $431.0 million and operating earnings were $44.5 million.
Cash from operating activities was $66.8 million for the nine months. Cash stood at $92.5 million with total debt of $176.3 million, including a $72.7 million Seller Note due in Q4 2025 and $104.0 million drawn on the revolving credit facility due 2028. The company repurchased 3.12 million shares for $55.0 million year to date, with $139.0 million remaining under authorization. Shares outstanding were 85,151,884 as of October 24, 2025.
Knowles Corporation filed an 8-K under Item 2.02 stating it has announced results for the quarter ended September 30, 2025. The company furnished a press release and presentation slides as Exhibits 99.1 and 99.2, and held its quarterly conference call and webcast on October 23, 2025. The materials are furnished, not filed, and therefore are not incorporated into Securities Act filings unless specifically referenced. The filing includes forward-looking statements language, noting estimates related to the expected impact, timing, and amounts of restructuring charges.
Knowles Corp (KN) insider Raymond D. Cabrera exercised non-qualified stock options on 08/25/2025, converting 24,116 options with an exercise price of $16.07 into 24,116 shares. The filing shows 20,795 shares were withheld/sold at $21.35 to cover the option exercise price and tax obligations. After the transactions the filing reports 114,607 shares beneficially owned by Mr. Cabrera (down from 135,402 prior to the disposition). The option exercised was originally granted 02/19/2020 and expires 02/19/2026. The form is signed by a POA on behalf of the reporting person.